Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1979 1
1997 1
2001 2
2002 1
2004 1
2005 1
2006 4
2007 3
2008 1
2010 3
2011 2
2012 5
2013 6
2014 6
2015 4
2016 7
2017 23
2018 13
2019 13
2020 25
2021 24
2022 45
2023 50
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Cardiac Fibrosis: The Fibroblast Awakens.
Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Travers JG, et al. Among authors: kamal fa. Circ Res. 2016 Mar 18;118(6):1021-40. doi: 10.1161/CIRCRESAHA.115.306565. Circ Res. 2016. PMID: 26987915 Free PMC article. Review.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Response.
Kamal F, Adler DG. Kamal F, et al. Gastrointest Endosc. 2023 Sep;98(3):470-471. doi: 10.1016/j.gie.2023.04.2066. Gastrointest Endosc. 2023. PMID: 37597942 No abstract available.
Considering the Treatment of IgA Nephropathy.
Lafayette RA, Kamal FS. Lafayette RA, et al. Among authors: kamal fs. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1113-1115. doi: 10.2215/CJN.0000000000000261. Epub 2023 Aug 3. Clin J Am Soc Nephrol. 2023. PMID: 37533148 No abstract available.
Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity.
Kamal FD, Dagar M, Reza T, Karim Mandokhail A, Bakht D, Shahzad MW, Silloca-Cabana EO, Mohsin SN, Chilla SP, Bokhari SFH. Kamal FD, et al. Cureus. 2023 Nov 24;15(11):e49339. doi: 10.7759/cureus.49339. eCollection 2023 Nov. Cureus. 2023. PMID: 38143595 Free PMC article. Review.
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae.
George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S, Kanwal A, Esneau C, Liu MKC, Kamal F, Man WD, Kaul S, Singh S, Lamb G, Faizi FK, Schuliga M, Read J, Burgoyne T, Pinto AL, Micallef J, Bauwens E, Candiracci J, Bougoussa M, Herzog M, Raman L, Ahmetaj-Shala B, Turville S, Aggarwal A, Farne HA, Dalla Pria A, Aswani AD, Patella F, Borek WE, Mitchell JA, Bartlett NW, Dokal A, Xu XN, Kelleher P, Shah A, Singanayagam A. George PM, et al. Among authors: kamal f. Sci Transl Med. 2022 Nov 16;14(671):eabo5795. doi: 10.1126/scitranslmed.abo5795. Epub 2022 Nov 16. Sci Transl Med. 2022. PMID: 36383686 Free article.
228 results